Meniere’s Disease Market Analysis, Leading Companies, Emerging Drugs and Epidemiology Forecast

Meniere's Disease Market Analysis, Leading Companies, Emerging Drugs and Epidemiology Forecast

DelveInsight Business Research LLP
DelveInsight’s “Meniere’s Disease Market Insights, Epidemiology, and Market Forecast 2030” report delivers an in-depth understanding of the Meniere’s Disease, historical and forecasted epidemiology as well as the Meniere’s Disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Meniere’s disease is one of the most common inner ear diseases characterized by episodic vertigo, sensorineural hearing loss that fluctuates during episodes, tinnitus, and ear fullness. In Ménière’s disease, fluid collects in the inner ear leading to pressure from the buildup of fluid that damages some of the delicate structures in the inner ear causing a variety of symptoms appearing suddenly, without warning, and can last minutes to hours.

Meniere’s disease is progressive on hearing levels of the patient; some of them develop profound hearing loss that also could affect the other ear. MD can be classified in various ways but primary classification of MD includes Classic MD, Vestibular MD and Bilateral MD. Classic MD is an inner ear disorder that is characterized by episodic vertigo attacks, sensorineural hearing loss, tinnitus, etc. However, in the Vestibular MD, hearing remains normal, and other aural symptoms (tinnitus, fullness) are absent. Bilateral MD is characterized by bilateral fluctuating hearing loss and recurrent episodes of vertigo. Approximately 50% of patients are destined to develop bilateral MD.


Get FREE sample copy at:



The Meniere’s Disease market report also covers emerging drugs, current treatment practices, Meniere’s Disease market share of the individual therapies, current and forecasted Meniere’s Disease Market Size from 2017 to 2030 segmented by seven major markets. 

The report provides a detailed current Meniere’s Disease treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses the underlying potential of the market. 


Meniere’s Disease Market Key Facts

As per the NIDCD estimates, approximately 615,000 individuals in the United States are currently diagnosed with Meniere’s Disease and that 45,500 cases are newly diagnosed each year.

The frequency of male/female prevalence in Meniere’s disease has been noted to be generally equal with perhaps some slight female preponderance up to 1.3:1.

According to study at Chicago Dizziness and Hearing, the prevalence of MD increases dramatically with age, peaking in the 60–69 years age group. It is very rare in people younger than 20 years



Key Benefits of Meniere’s Disease Market Report

  • Meniere’s Disease market report provides an in-depth analysis of Meniere’s Disease Market Size, Share, Trend, Epidemiology and Market Forecast till 2030, in 7 major market i.e. EU5 (Germany, Italy, Spain, France and the UK), Japan, and the United States.

  • The Meniere’s Disease market report will help in developing business strategies by understanding the Meniere’s Disease Market trends & developments, key players and future market competition that will shape and drive the Meniere’s Disease market in the upcoming years.

  • The Meniere’s Disease market report covers Meniere’s Disease current treatment practices, emerging drugs, market share of the individual therapies in 7 MM.

  • The report provides a detailed assessment of the Meniere’s Disease market in terms of market drivers & barriers, Unmet Needs, market opportunities, patient population,  comparative analysis of pipeline products with detailed clinical profiles, and other factors. 


Meniere’s Disease Market

There is no cure for Ménière’s disease, so treatment focuses on managing symptoms, hence ideal treatment aims to stop vertigo attacks, restore hearing, and get rid of tinnitus and ear fullness. Furthermore, all current treatment options are symptomatic with common treatments including salt restriction, diuretics and betahistine, intratympanic gentamicin and steroids, ablative surgical therapies endolymphatic sac surgery, and Meniett device.
The MD market is expected to grow in the coming years due to increased funding for new drugs development and clinical trials, increasing awareness among common people, the rapid growth of the geriatric population, and identification of potential biomarkers.

The Meniere’s Disease market outlook section of the report helps to build the detailed comprehension of the historic, current and forecasted Meniere’s Disease market trends by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand for better technology. 

The report gives a thorough detail of Meniere’s Disease market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, and view of the key opinion leaders. 


Meniere’s Disease Epidemiology

The Meniere’s Disease epidemiology section covers insights about historical and current Meniere’s Disease patient pool and forecasted trends for every seven major countries (i.e. the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2017 to 2030.

It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.  


Meniere’s Disease Drugs Uptake and Key Market Players

The Meniere’s Disease Drugs Uptake section focuses on the rate of uptake of the potential drugs recently launched in the Meniere’s Disease market or expected to get launched in the market during the study period. The analysis covers Meniere’s Disease market uptake by drugs; patient uptake by therapies; and sales of each drug.    

Report’s Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

Currently, companies worldwide are involved in developing therapies for Meniere’s Disease. Launch of emerging therapies are expected to significantly impact the treatment pattern of Meniere’s Disease in the upcoming years.

Some of the key companies in the Meniere’s Disease market includes:
Otonomy Inc.
Sound Pharmaceuticals
And many others


Drugs Covered
And many others.


Table of Content

1. Key Insights

2. Executive Summary 

3. Meniere’s Disease Competitive Intelligence Analysis

4. Meniere’s Disease Market Overview at a Glance

5. Meniere’s Disease Disease Background and Overview

6. Meniere’s Disease Patient Journey

7. Meniere’s Disease Epidemiology and Patient Population

8. Meniere’s Disease Treatment Algorithm, Current Treatment, and Medical Practices

9. Meniere’s Disease Unmet Needs

10. Key Endpoints of Meniere’s Disease Treatment

11. Meniere’s Disease Marketed Products

12. Meniere’s Disease Emerging Therapies

13. Meniere’s Disease Seven Major Market Analysis

14. Attribute Analysis

15. Meniere’s Disease Market Outlook (7 major markets)

16. Meniere’s Disease Access and Reimbursement Overview

17. KOL Views on the Meniere’s Disease Market.

18. Meniere’s Disease Market Drivers

19. Meniere’s Disease Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer


Related Reports

Meniere’s Disease (MD) Epidemiology Forecast to 2030

DelveInsight’s Meniere’s Disease (MD) Epidemiology Forecast 2030 report delivers an in-depth understanding of the disease, historical, and forecasted epidemiology of Meniere’s Disease (MD) in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.


Meniere’s Disease (MD) Pipeline Insights, 2020

Meniere’s Disease (MD) Pipeline Insight, 2020 report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Meniere’s Disease (MD) market.


About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end to end comprehensive solutions to improve their performance.


Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Anuj Rawat
Email: Send Email
Phone: +919650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States